1289 Predicting response to immune checkpoint inhibitors (ICI) in non-small-cell lung cancer (NSCLC) by combining spatial analysis of cells and RNA sequencing data from biopsies using deep learning (DL)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.